Elon, Inc: Elon's Bad Trip
Big Take9 Tammi 2024

Elon, Inc: Elon's Bad Trip

We here at Big Take are big fans of our colleagues and friends over at the Elon, Inc podcast from Businessweek, hosted by David Papadopoulos. Please enjoy this episode, and hop on over to subscribe to their feed if you like what you hear!
----

Were we talking about almost any other executive, the report by the Wall Street Journal over the weekend about Elon Musk’s alleged drug use would have qualified as a bombshell. The article contends the chief executive of SpaceX and Tesla has used a collection of substances. This, according to the Journal’s unidentified sources, has caused consternation within Musk’s companies, with Tesla board members and SpaceX executives privately expressing concerns that the alleged drug use may be making Musk unreliable and erratic.

But it’s not clear that many people, either inside or outside Musk’s companies, are genuinely worried. Musk mostly laughed off the report, offering a jokey response suggesting that any drugs he was taking should be seen as performance enhancers and noting that he’d passed government-mandated drug tests “after that one puff on Rogan”—a reference to a 2018 interview with Joe Rogan during which he smoked marijuana. Investors have been largely unmoved by all of this, partly because during the period that Musk is alleged to have indulged in illicit substances, he also made them a great deal of money. And Musk has mostly gone back to his regular schedule of boosting conspiracy theories proffered by election deniers, white nationalists and other assorted right wing influencers.

On this episode, we are joined by Loren Grush, a Bloomberg aerospace reporter and author of the NASA history, The Six, to discuss why these drug allegations haven’t hurt Musk and why a labor dispute involving SpaceX employees might be a bigger threat in the long run.

See omnystudio.com/listener for privacy information.

Jaksot(791)

The Kindbody Story: E4, Fertility Care, Meet Sales Targets

The Kindbody Story: E4, Fertility Care, Meet Sales Targets

Kindbody implements quotas requiring doctors to perform more lucrative procedures, internal company documents show. In Episode 4 of IVF Disrupted: The Kindbody Story, patients report being pushed toward expensive IVF cycles and questionable add-ons. Bloomberg’s Jackie Davalos investigates how financial pressure drove medical decisions at the struggling fertility chain—including one woman's painful and seemingly unnecessary procedure that would leave her questioning everything. Read more: IVF Disrupted: The Kindbody StorySee omnystudio.com/listener for privacy information.

26 Syys 202541min

Argentina’s Economy Is Struggling. Why Is the White House Stepping In?

Argentina’s Economy Is Struggling. Why Is the White House Stepping In?

This week, President Donald Trump and Treasury Secretary Scott Bessent surprised markets when they signaled broad economic support — including a potential $20 billion swap line — for Argentinian President Javier Milei amid deep financial and political uncertainty in South America’s second-largest economy. So, what’s behind this gesture and how would it work? On today’s episode, Bloomberg’s Patrick Gillespie joins Big Take host David Gura from Buenos Aires to unpack what US support could mean for Milei as he faces a referendum on his economic agenda. Read more: US Readies $20 Billion Rescue to Help Milei Win In ArgentinaSee omnystudio.com/listener for privacy information.

25 Syys 202517min

Trump vs. the UN

Trump vs. the UN

The United States is responsible for about 20% of the UN’s annual budget. But it hasn’t paid its dues in months. And the UN Secretary-General Antonio Guterres says the international body is now facing hard choices. On today’s Big Take podcast, host David Gura sits down with Guterres and Bloomberg’s Magdalena Del Valle to discuss whether the institution can survive funding cuts and prove its relevancy in a time of rising global tensions. Without the full backing of the US, how much can the UN do to promote peace and security around the world — and what will that mean for the people they support?See omnystudio.com/listener for privacy information.

24 Syys 202515min

Breaking Down the Proposed US-China TikTok Deal

Breaking Down the Proposed US-China TikTok Deal

After months of negotiation, the US and China have reached a tentative agreement to secure TikTok’s future in the US. On today’s Big Take Asia Podcast, host K. Oanh Ha sits down with Bloomberg’s Josh Wingrove and Mark Anderson to unpack TikTok’s “America-First” era. They discuss what you need to know about potential changes to the platform, how a majority American-controlled board could impact the app’s future and what the deal tells us about China-US negotiations moving forward. Read more: TikTok’s Algorithm to Be Secured by Oracle Under Trump Deal What We Do and Don’t Know About US TikTok Deal With China Further listening: Americans Flocked to RedNote as the TikTok Ban Loomed. Will the Party Last?See omnystudio.com/listener for privacy information.

23 Syys 202518min

How Private Equity Lost Its Mojo

How Private Equity Lost Its Mojo

Fewer deals. Long wait times for returns on investments. Struggles with fundraising. Even with an interest rate cut, private equity, which thrives on flipping and selling companies for a profit, is in a slump. What would it take for the industry to bounce back? On today’s Big Take podcast, private equity reporter Allison McNeely on what’s contributing to an existential slowdown that has private equity firms scrambling to find a path forward.See omnystudio.com/listener for privacy information.

22 Syys 202517min

The Kindbody Story: E3, Rocketship to Nowhere

The Kindbody Story: E3, Rocketship to Nowhere

Kindbody doubles its size overnight through a major acquisition, with executives telling employees they'll be rich enough to buy private jets. In Episode 3 of IVF Disrupted: The Kindbody Story, Bloomberg reporter Jackie Davalos reports on internal documents revealing that the company is hemorrhaging cash. As layoffs reduce the number of patient-facing employees, one clinic's staffing crunch sets the stage for an error that led one woman to give up on her dream of motherhood. Read more: IVF Disrupted: The Kindbody StorySee omnystudio.com/listener for privacy information.

21 Syys 202533min

The Kindbody Story: E2, The Embryo Mixup

The Kindbody Story: E2, The Embryo Mixup

Dina and B arrive at Kindbody for the embryo transfer they've dreamed about for years. But their doctor delivers news that will make them question whether coming to Kindbody was a mistake. In Episode 2 of IVF Disrupted: The Kindbody Story, Bloomberg reporter Jackie Davalos investigates what went wrong and discovers that this error wasn't an isolated incident. Read more: IVF Disrupted: The Kindbody StorySee omnystudio.com/listener for privacy information.

20 Syys 202536min

The Kindbody Story: E1, The Fertility Spa

The Kindbody Story: E1, The Fertility Spa

In 2018 a startup emerged, aiming to revolutionize fertility care with spa-like clinics and Silicon Valley swagger. Kindbody attracted millions from investors eager to disrupt a booming industry. But former employees describe a company that at times cut too many corners as it raced to expand. In Episode 1 of IVF Disrupted: The Kindbody Story, reporter Jackie Davalos investigates what can happen when startup culture collides with the delicate science of creating life. Read more: IVF Disrupted: The Kindbody StorySee omnystudio.com/listener for privacy information.

19 Syys 202531min

Suosittua kategoriassa Politiikka ja uutiset

aikalisa
rss-ootsa-kuullut-tasta
ootsa-kuullut-tasta-2
tervo-halme
rss-kuka-mina-olen
et-sa-noin-voi-sanoo-esittaa
politiikan-puskaradio
rss-vaalirankkurit-podcast
otetaan-yhdet
rikosmyytit
rss-podme-livebox
aihe
radio-antro
rss-raha-talous-ja-politiikka
rss-tasta-on-kyse-ivan-puopolo-verkkouutiset
rss-merja-mahkan-rahat
rss-skn-parhaat